It is time for the celebration for the patients suffering from advanced melanoma. The new drugs in the clinical trials are showing the promising results in increasing the life span of patients suffering from advanced Melanoma.
The recent clinical trials conducted to conclude the efficiency of the drug showed the positive results. The active group of the clinical trial showed an increase in the lifespan when compared to the controlled group. The risk of losing the life was reduced to 63 percent. The drug showed the positive results by working in two ways, one by combating cancer by attacking specific genetic mutation that accelerates the tumor growth. The second way is by unleashing body’s immune system to fight the diseases.
No comments:
Post a Comment